Ally Speight

799 total citations
14 papers, 179 citations indexed

About

Ally Speight is a scholar working on Oncology, Genetics and Epidemiology. According to data from OpenAlex, Ally Speight has authored 14 papers receiving a total of 179 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Genetics and 3 papers in Epidemiology. Recurrent topics in Ally Speight's work include Inflammatory Bowel Disease (5 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Neutropenia and Cancer Infections (2 papers). Ally Speight is often cited by papers focused on Inflammatory Bowel Disease (5 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Neutropenia and Cancer Infections (2 papers). Ally Speight collaborates with scholars based in United Kingdom. Ally Speight's co-authors include David Jones, Vinod S. Hegade, Rachel Etherington, John Mansfield, Simon Panter, Stephanie Needham, Mark Verrill, Lavinia Spain, Christopher J. Stewart and Christopher A Lamb and has published in prestigious journals such as Journal of Clinical Oncology, BMC Cancer and Journal for ImmunoTherapy of Cancer.

In The Last Decade

Ally Speight

10 papers receiving 168 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ally Speight United Kingdom 7 63 50 45 42 35 14 179
Kassiani Skordilis United Kingdom 6 54 0.9× 24 0.5× 29 0.6× 54 1.3× 48 1.4× 12 204
O. V. Knyazev Russia 8 25 0.4× 96 1.9× 114 2.5× 7 0.2× 50 1.4× 75 192
Anja Ernst Denmark 11 33 0.5× 88 1.8× 121 2.7× 9 0.2× 61 1.7× 27 302
A. Canossi Italy 9 36 0.6× 28 0.6× 33 0.7× 21 0.5× 26 0.7× 42 256
Guangyu Sun China 8 64 1.0× 26 0.5× 12 0.3× 61 1.5× 12 0.3× 39 213
Ali Abdul‐Hai Israel 8 95 1.5× 33 0.7× 13 0.3× 84 2.0× 18 0.5× 18 258
Anneline Cremer Belgium 9 21 0.3× 129 2.6× 162 3.6× 13 0.3× 73 2.1× 21 219
Yael Klionsky United States 8 30 0.5× 44 0.9× 30 0.7× 42 1.0× 26 0.7× 18 196
Maxime Audet France 10 24 0.4× 56 1.1× 43 1.0× 37 0.9× 191 5.5× 15 290
F. Schillo France 7 16 0.3× 52 1.0× 18 0.4× 13 0.3× 64 1.8× 10 182

Countries citing papers authored by Ally Speight

Since Specialization
Citations

This map shows the geographic impact of Ally Speight's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ally Speight with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ally Speight more than expected).

Fields of papers citing papers by Ally Speight

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ally Speight. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ally Speight. The network helps show where Ally Speight may publish in the future.

Co-authorship network of co-authors of Ally Speight

This figure shows the co-authorship network connecting the top 25 collaborators of Ally Speight. A scholar is included among the top collaborators of Ally Speight based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ally Speight. Ally Speight is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Gault, Abigail, Linda Hogarth, Alastair Greystoke, et al.. (2024). Monitoring immunE DysregulAtion foLLowing Immune checkpOint-inhibitioN (MEDALLION): protocol for an observational cancer immunotherapy cohort study. BMC Cancer. 24(1). 733–733. 5 indexed citations
3.
Nylander, David, John Leeds, John D. Perry, et al.. (2023). Bacterial contamination of endoscopist and assistant face visors during gastrointestinal endoscopy: a pilot study. Frontline Gastroenterology. 14(6). 505–511. 1 indexed citations
4.
Quraishi, Mohammed Nabil, Shahida Din, Fraser Cummings, et al.. (2023). Establishing key performance indicators for inflammatory bowel disease in the UK. Frontline Gastroenterology. 14(5). 407–414. 7 indexed citations
5.
Lamb, Chris, et al.. (2023). P50 Is there evidence of geographical clustering of inflammatory bowel disease in Newcastle upon Tyne?. Poster presentations. A71.2–A72. 1 indexed citations
6.
Alexander, James L., Hajir Ibraheim, Benjamin Shum, et al.. (2022). Oral beclomethasone dipropionate is an effective treatment for immune checkpoint inhibitor induced colitis. Journal for ImmunoTherapy of Cancer. 10(9). e005490–e005490. 6 indexed citations
7.
Speight, Ally, et al.. (2021). Targeting Leukocyte Trafficking in Inflammatory Bowel Disease. BioDrugs. 35(5). 473–503. 7 indexed citations
8.
9.
10.
Powell, Nick, Hajir Ibraheim, Tim Raine, et al.. (2020). British Society of Gastroenterology endorsed guidance for the management of immune checkpoint inhibitor-induced enterocolitis. ˜The œLancet. Gastroenterology & hepatology. 5(7). 679–697. 37 indexed citations
11.
Hegade, Vinod S., Ally Speight, Rachel Etherington, & David Jones. (2016). Novel bile acid therapeutics for the treatment of chronic liver diseases. Therapeutic Advances in Gastroenterology. 9(3). 376–391. 39 indexed citations
12.
Speight, Ally & John Mansfield. (2013). Drug advances in inflammatory bowel disease. Clinical Medicine. 13(4). 378–382. 13 indexed citations
13.
Speight, Ally, et al.. (2013). Rare, Germline Mutation of KIT With Imatinib-Resistant Multiple GI Stromal Tumors and Mastocytosis. Journal of Clinical Oncology. 31(16). e245–e247. 17 indexed citations
14.
Donohoe, W. T. A., R. Finn, Rob McConnell, et al.. (1966). Prevention of Rh-haemolytic disease: results of the clinical trial. A combined study from centres in England and Baltimore.. BMJ. 2(5519). 907–914. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kassiani Skordilis Breakdown of academic impact, for papers by O. V. Knyazev Breakdown of academic impact, for papers by Anja Ernst Breakdown of academic impact, for papers by A. Canossi Breakdown of academic impact, for papers by Guangyu Sun Breakdown of academic impact, for papers by Ali Abdul‐Hai Breakdown of academic impact, for papers by Anneline Cremer Breakdown of academic impact, for papers by Yael Klionsky Breakdown of academic impact, for papers by Maxime Audet Breakdown of academic impact, for papers by F. Schillo
Rankless by CCL
2026